With this operation, the Baker Bros aim to have the monopoly of Rett syndrome (Anavex aside), it is a long story starting from Aquinox where they held 40% then merged with Neoleukin where they are currently the first fund but hold just under 10% , yesterday new merger between Neoleukin and Neurogene, below the new adventure:
https://investor.neoleukin.com/news...eoleukin-announce-definitive-merger-agreement
Ann: Neuren and Acadia expand global partnership for trofinetide, page-142
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.40 |
Change
-0.140(1.12%) |
Mkt cap ! $1.543B | |||
| Open | High | Low | Value | Volume |
| $12.61 | $12.68 | $12.34 | $2.980M | 238.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 32 | $12.38 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.40 | 4820 | 7 |
View Market Depth
| Last trade - 12.47pm 25/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |